Evidence map›Paper›PMID 41221058›Full record

ReviewNational science review2025

Current status and future prospects of non-toxicity carbon-dot-based miniaturized lasers.

Yongqiang Zhang, Xiao Zeng, Xinyi Wen, Shurong Ding, Yuzhuo Yang, Yongsheng Hu, Siyu Lu

Abstract readReview
In one paragraph

Review in National science review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yongqiang ZhangCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China.
Xiao ZengCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China.
Xinyi WenCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China.
Shurong DingCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China.
Yuzhuo YangCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China.
Yongsheng HuSchool of Physics and Microelectronics, Zhengzhou University, Zhengzhou 450001, China.
Siyu LuCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With rapid advances in on-chip photonic integration and flexible optoelectronic devices, miniaturized laser devices are increasingly desired for various fields including optical communication, biosensing and biomedicine. However, a major barrier to their industrial deployment is the development of solution-processable gain media that are affordable, non-toxic and highly stable. Conventional solution-processable gain media often exhibit high toxicity and limited optical stability, considerably restricting their scalability and practical use. Carbon dots (CDs), as emerging solution-processable gain media, offer a compelling solution for developing environmentally friendly miniaturized lasers owing to their simple synthesis, affordability, non-toxicity, high biocompatibility, superior stability and excellent optical properties. This review summarizes progress in CD-based lasers with diverse resonator configurations, elucidates their gain mechanisms in the context of CD luminescence theories, and proposes strategies to optimize laser performance. Furthermore, it discusses current application prospects alongside critical challenges that must be addressed to advance CD-based miniaturized lasers. Overall, this review highlights the promising nature of CD-based miniaturized lasers and is anticipated to drive further in-depth research in this field.

Indexed as

biocompatibilitycarbon dotsminiaturized lasersnon-toxicitysolution-processable gain media

Identifiers

PMID41221058
PMCPMC12598612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.